



COVID-19 patients are being treated with drugs such as itolizumab even though there is insufficient evidence on their efficacy against the disease
Divya Trivedi Siddhartha Das Venkitesh RamakrishnanSome pharma companies appear to be using the ongoing pandemic as an excuse to bypass some of the necessary steps to get government approvals so that t
